Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ProBioGen AG
ProBioGen AG
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
ProBioGen and DIOSynVax partner to manufacture multivalent vaccine for hemorrhagic fever
The novel vaccine targets HF diseases caused by Ebola, Marburg, and Lassa viruses
Regulatory
ProBioGen granted new patent for DirectedLuck transposase technology
ProBioGen announces that the Japan Patent Office (JPO) issued the first patent for the company’s DirectedLuck technology
Drug Delivery
ProBioGen and ImmunOs Therapeutics team up on therapy for cancer patients
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic
Manufacturing
ProBioGen enters technology collaboration with Boehringer Ingelheim
It contributes to Boehringer Ingelheim's goal of using cutting-edge technologies across the whole biopharmaceutical value chain
Manufacturing
ProBioGen and Thermo Fisher Scientific team up on cell platform
The new kit uses Thermo Fisher's ExpiCHO-S cell line and a new powerful media platform specifically developed for it
Manufacturing
ProBioGen and City of Hope announce commercial licence for manufacturing
The agreement will allow City of Hope to manufacture its MVA-based CMV vaccine using ProBioGen’s platform
Manufacturing
ProBioGen chooses NextPoint for GMP manufacturing of antibody
NextPoint has been selected to fast track CMC development and manufacturing of this unique antibody that targets a novel immune checkpoint axis offering promise for hard-to-treat cancers
Subscribe now